# N-acetylcysteine for Primary Sjögren's Syndrome

> **NCT04793646** · NA · COMPLETED · sponsor: **University of Sao Paulo General Hospital** · enrollment: 60 (actual)

## Conditions studied

- Sjögren Syndrome
- Sicca Syndrome

## Interventions

- **DRUG:** N-acetylcysteine syrup
- **DRUG:** Placebo syrup

## Key facts

- **NCT ID:** NCT04793646
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-30
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-01-21
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04793646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04793646, "N-acetylcysteine for Primary Sjögren's Syndrome". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04793646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*